Recent studies have shown that PDT extensively sensitizes refractory colon tumors to death signals delivered by long-acting TRAIL [53], possibly by increasing the levels of TRAIL receptors on tumor cells. This evidence concerns the gene TNFSF10 and colonic neoplasm.